Search results for: England
Filter search results
Comparing Economic Appraisal Guides in England
10 August 2010
Debate continues about the methods that the UK’s NICE uses in its appraisals of medical technologies, including whether effects beyond the NHS should be considered using a cost-benefit approach. Examining…
Recent Statistics on Orphan Approvals in Scotland and England
23 August 2011
In October 2009, the OHE published research that compared access to orphan medicinal products (OMPs) in selected European countries. At the request of the UK Orphan Medicines Industry Group [1],…
How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England
1 September 2009
Written while Labour Government policies still were in force, this Briefing clearly and thoroughly examines non-discretionary cost differences between public and independent providers that may have a serious impact on…
How Important are the Differences Between the EQ-5D-5L and EQ-5D-3L Value Sets?
24 March 2017
There are three EQ-5D value sets available for use in cost effectiveness analysis in the UK and/or England: – the UK EQ-5D-3L value set (often called the ‘MVH’ value set)…
Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
18 December 2017
…the period of interest this includes 61 products directly funded by NHS England specialised commissioning. We identified 25 orphan medicinal products that were directly commissioned by NHS England. Additionally despite…
NICE at 25: Technology Appraisals – Faster Access to Modern Treatment?
1 May 2024
…categories enhanced NICE HTA methodology, formalising the principle of funding with evidence collection. NICE and NHS England Further reorganisation of the NHS in 2011 saw the creation of NHS England….
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
…for 10 years, which may not be sufficient to constitute England’s fair share (see Brassel et al., 2023) of a global pull incentive. Following the pilot, NHS England published proposals for a new scheme…
Can we “Netflix” the Broken Antibiotics Market?
28 September 2022, 3:00pm
…NHS England to develop and test innovative models for the evaluation and purchase of antimicrobials. David Glover, Deputy Head of the Medicines Analysis Team at NHS England and Improvement David…
OHE Awarded £457K Grant on Measuring Public Preferences for Health States
2 August 2012
…Institute for Health Research (NIHR) for research to produce an EQ-5D-5L Value Set for England. Prof Nancy Devlin OHE’s Prof Nancy Devlin and Prof Ben van Hout of the…